Estrella Immunopharma, Inc

The annual 10-K, the quarterly 10-Q and the 8-K filed between them when something material happens.

1. Sep 88-KListing notice or transfer3.01
2. Aug 218-KListing notice or transfer3.01
3. Aug 1310-QQuarterly report
4. Jun 308-KShareholder vote5.07
5. May 1610-QQuarterly report
6. Mar 1810-KAnnual report
7. Feb 13424B3Prospectus for an offering
8. Jan 138-KListing notice or transfer3.01
9. Jan 68-KMaterial agreement and unregistered sale of shares1.013.027.019.01
10. Jan 6424B5Prospectus for an offering
11. Dec 22, 2025S-1Registration of new shares
12. Dec 4, 20258-KOther events8.019.01
13. Nov 12, 202510-QQuarterly report
14. Nov 6, 20258-KOther events8.019.01
15. Sep 29, 20258-KOther events8.01
16. Sep 26, 20258-KOfficer or director change5.02
17. Aug 12, 202510-QQuarterly report
18. Aug 7, 20258-KListing notice or transfer3.01
19. Jun 5, 20258-KOther events8.019.01
20. Jun 3, 20258-KMaterial agreement and unregistered sale of shares1.013.028.019.01
21. May 29, 20258-KOther events8.019.01
22. May 14, 202510-QQuarterly report
23. May 2, 20258-KListing notice or transfer3.01
24. Feb 21, 20258-KOther events8.019.01
25. Feb 19, 20258-KOther events8.019.01
26. Dec 17, 2024424B3Prospectus for an offering
27. Dec 16, 20248-KOther events8.01
28. Dec 12, 2024S-3Shelf registration
29. Dec 9, 2024424B3Prospectus for an offering
30. Dec 6, 20248-KMaterial agreement1.019.01
31. Nov 27, 2024424B3Prospectus for an offering
32. Nov 26, 20248-KBylaws or fiscal year changed5.039.01
33. Nov 25, 20248-KListing notice or transfer3.01
34. Nov 18, 2024424B3Prospectus for an offering
35. Nov 14, 202410-QQuarterly report
36. Nov 7, 20248-K/AMaterial agreement and officer or director change (amended)1.015.029.01
37. Nov 7, 20248-KOfficer or director change5.029.01